Glucose Measurement of Intensive Care Unit Patient Plasma Samples Using a Fixed-Wavelength Mid-Infrared Spectroscopy System
Autor: | Kelly Bochicchio, James S. Krinsley, Grant V. Bochicchio, Christopher Calentine |
---|---|
Rok vydání: | 2012 |
Předmět: |
Adult
Blood Glucose Male medicine.medical_specialty Adolescent Critical Illness Endocrinology Diabetes and Metabolism Biomedical Engineering Bioengineering law.invention Young Adult Predictive Value of Tests law Spectroscopy Fourier Transform Infrared Internal Medicine medicine Humans Prospective Studies Intensive care medicine Prospective cohort study APACHE Aged Monitoring Physiologic Glycemic Metoprolol Aged 80 and over business.industry Glucose Measurement Reproducibility of Results Signal Processing Computer-Assisted Middle Aged Reference Standards Intensive care unit Connecticut Intensive Care Units Standard error Predictive value of tests Baltimore Emergency medicine Linear Models Feasibility Studies Original Article Female Volume expander business Algorithms Biomarkers medicine.drug |
Zdroj: | Journal of Diabetes Science and Technology. 6:294-301 |
ISSN: | 1932-2968 |
DOI: | 10.1177/193229681200600212 |
Popis: | Objective: Glycemic control is a rapidly developing field in intensive care medicine with the aim of reducing mortality, morbidity, and cost. Current intensive care unit (ICU) glucose measurement technologies are susceptible to interference from medications, volume expanders, and other substances present in critically ill patients. We hypothesized that a fixed-wavelength mid-infrared (mid-IR) spectroscopy system would be accurate for measuring glucose levels of ICU patients. Research Design and Methods: This is a prospective investigation of plasma samples from two different institutions treating a heterogeneous population of ICU patients. The first 292 samples were collected from 86 patients admitted to Stamford Hospital, and the next 352 samples were collected from 75 patients from three ICUs at the University of Maryland. Plasma samples were measured on a Fourier-transform infrared or a proprietary spectrometer, with a glucose prediction algorithm to correct for spectral interference, which were compared with reference measurements taken using a YSI 2300 glucose analyzer. Results: Glucose values ranged from 24 to 343 mg/dl. Numerous medications and injury/disease states were observed in the patient populations, with metoprolol, fentanyl, and multiple organ failure the most prevalent. Despite these interferents, there was a high correlation (r ≥ 0.94) and low standard error (≤12.8 mg/dl) between the predicted glucose values and those of the YSI 2300 STAT Plus reference instrument in the three studies. A total of 95.1% of the 644 values in the three studies met International Organization for Standardization 15197 criteria. Conclusion: These results suggest that a fixed-wavelength mid-IR spectrometer can measure glucose accurately in the plasma of ICU patients. |
Databáze: | OpenAIRE |
Externí odkaz: |